Dear reader,
This issue of Human Vaccines & Immunotherapeutics features two research articles on HPV vaccines. One investigates a link between immunization and infection in young women (Guo, p 2337), and the other discusses the impact of vitamin D on antibody production after vaccination (Zimmerman, p 2345).
We are happy to introduce four articles on Influenza. A review on protection offered by universal pediatric vaccination (Principi, p 2350), two clinical trials investigating the immune response induced by two doses of an AS03-adjuvanted A(H1N1)pdm09 vaccine (Garcia-Sicilia, p 2359), a study of immunogenicity and safety of inactivated trivalent vaccine (Roggelin, p 2370), and an analysis of public awareness and preference for pandemic influenza vaccination in India (Sundaram, p 2376).
Two Public Health papers deal with optimal vaccination program for healthy adults in China (Yao, p 2389) and the use of mobile applications in vaccinology (Wilson, p 2395).
We present eight articles in the Licensed Vaccines section: an analysis of enterovirus 71-associated disease burden in rural China (Gan, p 2400), a preclinical study of the ability of EV71 VLP vaccine to protect from a lethal challenge (Sun, p 2406), a report on the development of a nano-based Human EV71 mucosal vaccine (Saeed, p 2414), immunogenicity and safety study of PPV23 in healthy Chinese subjects aged >2 years (Kong, p 2425), an analysis of the sero-epidemiology of diphtheria and pertussis in Beijing (Li, p 2434), clinical study of a tetanus-diphtheria toxoid vaccine in healthy adults (Hong, p 2440), a report showing the importance of optimization of in vivo assays for the evaluation of mumps vaccine strain immunogenicity (Halassy, p 2446), and a commentary on the recommended vaccines for international travelers to India (Verma, p 2455).
Three articles in the Immunotherapy section include a review on T-cell immunoglobulin and mucin domain (Tim) proteins as targets in cancer therapy (Cheng, p 2458), a commentary on small molecule immunomodulators with anti-tumor potential (Murphy, p 2463), and a clinical study of the PSA-TRICOM vaccine administered with docetaxel and its effect on castrate-resistant metastatic prostate cancer (McNeel, p 2469).
Two research articles on Rotavirus report on the reduction of hospitalization of children after the introduction of universal immunization in Israel (Muhsen, p 2475) and preclinical immunogenicity of a recombinant subunit vaccine candidate (Wen, p 2483). We also introduce an analysis of Hepatitis B DNA levels in liver transplant recipients who were vaccinated against HBV reinfection (Duan, p 2490).
We conclude this issue with three commentaries on Novel Vaccines, namely, Acinetobacter vaccines—advances and challenges (Chen, p 2495), nanoparticle vaccines for listeriosis (Calderon-Gonzalez, p 2501), and schistosome vaccines in development (Ricciardi, p 2504).
Our monthly News, Policy and Profiles (NP&P) track offers a selection of the latest news in the field of vaccines and immunotherapeutics. In this section we also regularly publish opinion pieces on timely, interesting and controversial topics related to vaccines and immunotherapeutics, profiles of companies and organizations, as well as portraits of distinguished scientists in our field. Please contact Acquisitions Editor Adam Weiss ([email protected]) with your ideas for commentaries, opinion pieces, profiles and portraits. Your suggestions for and contributions to our N&P&P track are always welcome!
Sincerely,
Ronald Ellis, PhD
Editor-in-Chief
Adam Weiss
Acquisitions Editor